The “Liraglutide market” report has been added to ReportHive.com Offering
This report studies the global Liraglutide market status and forecast, categorizes the global Liraglutide market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
Free sample available here-> https://www.reporthive.com/enquiry.php?id=1546190&req_type=smpl
The major players covered in this report
Shenzhen JYMed Technology
If you have any special requirements, please let us know and we will offer you the report as you want.
Get discount from here: https://www.reporthive.com/enquiry.php?id=1546190&req_type=disc
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- Southeast Asia
- India etc…
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
The study objectives of this report are:
To analyze and study the global Liraglutide sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Liraglutide players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
Liraglutide Subcomponent Manufacturers
Purchase report from here-> https://www.reporthive.com/enquiry.php?id=1546190&req_type=purch
Get Detail Analysis on Table of Content and List of Figure
Global Liraglutide Market Professional Survey Report 2018
1 Industry Overview of Liraglutide
2 Global Liraglutide Competition by Players/Suppliers, Type and Application
3 United States Liraglutide (Volume, Value and Sales Price)
4 Europe Liraglutide (Volume, Value and Sales Price)
5 China Liraglutide (Volume, Value and Sales Price)
6 Japan Liraglutide (Volume, Value and Sales Price)
Browse full table of contents from here with list of figures: https://www.reporthive.com/details/global-liraglutide-sales-market-2018-5b1f6f5c5d994
Phone Number: +1-312 604 7084